Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size study, By Drug (Monoclonal Antibodies, Immunomodulators, Cancer Vaccines and Oncolytic Therapies and Others }, Service (Target Identification and Validation, Lead screening and Characteriz

Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size study, By Drug (Monoclonal Antibodies, Immunomodulators, Cancer Vaccines and Oncolytic Therapies and Others }, Service (Target Identification and Validation, Lead screening and Characterization, Cell based Assays), By Cancer Type ( Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Ovarian Cancer and Pancreatic Cancer), and Regional Forecasts 2022-2028

Global Cancer Immunotherapy Drug Discovery Outsourcing Market is valued approximately USD 1.0 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.5% over the forecast period 2022-2028.

The popularity of the market is expanding as more doctors and patients are becoming aware of cancer immunotherapy, pharmaceutical and biotechnology companies are investing more in the research and development of cancer treatments, and the incidence of cancer is rising globally. Pharmaceutical corporations are also becoming more interested in immunotherapies as they lower the risk of cancer and demonstrate a decrease in tumour recurrence following chemotherapy. For instance, globally, there were 17.0 million new instances of cancer and 9.5 million cancer-related deaths in 2018, according to estimates from the International Agency for Research on Cancer (IARC). The estimated increase in the worldwide burden of cancer to 27.5 million new cases by 2040. Consequentially, growing mergers and acquisition is creating a new opportunity to the market. However, quality issues involved with drug discovery CRO services and intellectual property right issues impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Cancer Immunotherapy Drug Discovery Outsourcing Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to presence of various large number of biotechnology and life sciences companies and key CROs in the region. Furthermore, government support towards cancer immunotherapy drug discovery outsourcing. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028 owing to increasing number of CROs that offers cost-effective drug discovery services, rise in use of advance technology, and large number of market players comply with Good Laboratory Practices (GLP) and follows regulatory guidelines effectively.

Major market players included in this report are:
Explicyte Immuno-Oncology
Aquila Biomedical
Horizon Discovery Group plc
Crown Bioscience Inc.
Promega Corporation.
HD Co. Ltd.
BPS Biosciences Inc.
Gen script Biotech Corporation
Celentyx Ltd.
ImmuneXperts SA

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug
Monoclonal Antibodies
Immunomodulators
Cancer Vaccines and Oncolytic Therapies
Others
By service:
Target Identification and Validation
Lead screening and Characterization
Cell based Assays
By Cancer Type
Lung Cancer
Breast Cancer
Colorectal Cancer
Melanoma
Prostate Cancer
Head and Neck Cancer
Ovarian Cancer
Pancreatic Cancer
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Cancer Immunotherapy Drug Discovery Outsourcing Market Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Explicyte Immuno-Oncology
Aquila Biomedical
Horizon Discovery Group plc
Crown Bioscience Inc.
Promega Corporation.
HD Co. Ltd.
BPS Biosciences Inc.
Gen script Biotech Corporation
Celentyx Ltd.
ImmuneXperts SA

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.